Stereotactic body radiotherapy for an isolated splenic metastasis from ovarian carcinoma

Ryan T. Hughes; Michael H. Soike; Surendra Prajapati; Andrew Q. Lin; James D. Ververs; Adrianna H. Masters; Corbin A. Helis; A. William Blackstock; Michael K. Farris

Stereotactic body radiotherapy for an isolated splenic metastasis from ovarian carcinoma

Ryan T. Hughes, Michael H. Soike, Surendra Prajapati, Andrew Q. Lin, James D. Ververs, Adrianna H. Masters, Corbin A. Helis, A. William Blackstock, Michael K. Farris

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Splenic metastases from oligometastatic ovarian carcinoma are a rare occurrence. Usual treatment for splenic metastases includes splenectomy, but some patients are either unable or unwilling to undergo surgery. Stereotactic body radiotherapy (SBRT) is an effective ablative modality for treating metastatic disease. SBRT to abdominopelvic tumors has been shown to be safe and effective for properly-selected patients and is particularly attractive in the oligometastatic setting as an alternative to radical resection. In this case study, we report a patient with an isolated splenic metastasis from ovarian carcinoma treated with 50 Gy in 10 fractions.

Original language	English (US)
Pages (from-to)	161-163
Number of pages	3
Journal	Journal of Radiosurgery and SBRT
Volume	6
Issue number	2
State	Published - Jan 1 2019
Externally published	Yes

Keywords

Isolated splenic metastasis
Ovarian carcinoma
Spleen metastasis
Stereotactic body radiotherapy

ASJC Scopus subject areas

Surgery
Radiological and Ultrasound Technology
Radiology Nuclear Medicine and imaging

Cite this

@article{3d70e4312ad74db0982481a5afff3fdf,

title = "Stereotactic body radiotherapy for an isolated splenic metastasis from ovarian carcinoma",

abstract = "Splenic metastases from oligometastatic ovarian carcinoma are a rare occurrence. Usual treatment for splenic metastases includes splenectomy, but some patients are either unable or unwilling to undergo surgery. Stereotactic body radiotherapy (SBRT) is an effective ablative modality for treating metastatic disease. SBRT to abdominopelvic tumors has been shown to be safe and effective for properly-selected patients and is particularly attractive in the oligometastatic setting as an alternative to radical resection. In this case study, we report a patient with an isolated splenic metastasis from ovarian carcinoma treated with 50 Gy in 10 fractions.",

keywords = "Isolated splenic metastasis, Ovarian carcinoma, Spleen metastasis, Stereotactic body radiotherapy",

author = "Hughes, {Ryan T.} and Soike, {Michael H.} and Surendra Prajapati and Lin, {Andrew Q.} and Ververs, {James D.} and Masters, {Adrianna H.} and Helis, {Corbin A.} and Blackstock, {A. William} and Farris, {Michael K.}",

year = "2019",

month = jan,

day = "1",

language = "English (US)",

volume = "6",

pages = "161--163",

journal = "Journal of Radiosurgery and SBRT",

issn = "2156-4639",

publisher = "Old City Publishing",

number = "2",

}

TY - JOUR

T1 - Stereotactic body radiotherapy for an isolated splenic metastasis from ovarian carcinoma

AU - Hughes, Ryan T.

AU - Soike, Michael H.

AU - Prajapati, Surendra

AU - Lin, Andrew Q.

AU - Ververs, James D.

AU - Masters, Adrianna H.

AU - Helis, Corbin A.

AU - Blackstock, A. William

AU - Farris, Michael K.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Splenic metastases from oligometastatic ovarian carcinoma are a rare occurrence. Usual treatment for splenic metastases includes splenectomy, but some patients are either unable or unwilling to undergo surgery. Stereotactic body radiotherapy (SBRT) is an effective ablative modality for treating metastatic disease. SBRT to abdominopelvic tumors has been shown to be safe and effective for properly-selected patients and is particularly attractive in the oligometastatic setting as an alternative to radical resection. In this case study, we report a patient with an isolated splenic metastasis from ovarian carcinoma treated with 50 Gy in 10 fractions.

AB - Splenic metastases from oligometastatic ovarian carcinoma are a rare occurrence. Usual treatment for splenic metastases includes splenectomy, but some patients are either unable or unwilling to undergo surgery. Stereotactic body radiotherapy (SBRT) is an effective ablative modality for treating metastatic disease. SBRT to abdominopelvic tumors has been shown to be safe and effective for properly-selected patients and is particularly attractive in the oligometastatic setting as an alternative to radical resection. In this case study, we report a patient with an isolated splenic metastasis from ovarian carcinoma treated with 50 Gy in 10 fractions.

KW - Isolated splenic metastasis

KW - Ovarian carcinoma

KW - Spleen metastasis

KW - Stereotactic body radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=85071450781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071450781&partnerID=8YFLogxK

M3 - Article

C2 - 31641553

AN - SCOPUS:85071450781

SN - 2156-4639

VL - 6

SP - 161

EP - 163

JO - Journal of Radiosurgery and SBRT

JF - Journal of Radiosurgery and SBRT

IS - 2

ER -

Stereotactic body radiotherapy for an isolated splenic metastasis from ovarian carcinoma

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this